Hints and tips:
Related Special Reports
The FT’s fifth annual ranking of the region’s businesses by revenue growth. Plus: outsourcers tap into remote work boom; Shopify targets more growth from bigger clients; Brazil’s alternative to electric vehicles; and Vertex Pharmaceutical’s potential answer to the opioid crisis
Food and Drug Administration poised to call for outside assessment of Lykos PTSD therapy in test for psychedelics sector
...It is struggling to raise enough funding for clinical trials, because metformin is a generic drug, so offers insufficient profit to pharmaceutical companies....
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
...Pfizer: The pharmaceutical company is expected to report that quarterly revenue declined 23.4 per cent from the same period last year to $14bn, according to LSEG, as the company faces weak demand for its...
...California has taken a first step to push down pharmaceutical prices in the US state, striking a deal with the maker of a drug that can reverse opioid overdoses to purchase the medicine at a large discount...
...Moderna: The pharmaceutical group will hold its annual investor day, when shareholders will be keen to learn more about how it plans to grow its business beyond the Covid-19 pandemic....
...Friday’s decision comes after the state of New Hampshire failed in its bid to receive FDA permission because it did not identify a pharmaceutical wholesaler which could deliver the drugs....
...Orchard, a UK-based biotech that was recently bought by Japanese pharmaceutical group Kyowa Kirin, argued that the lack of other treatments for MLD justified the price....
...This month Brazil started distributing a vaccine produced by Japanese pharmaceutical group Takeda....
...The US market is the engine of the global pharmaceutical industry. Its exceptionally high drug prices help deliver as much as three-quarters of the sector’s global profits....
Drug developers raised $6bn in January, helped by a rebound in merger activity
...We reveal today how 50 corporate winners from the pandemic have lost roughly $1.5tn in market value since the end of 2020, as investors ditch the ecommerce, home entertainment and pharmaceutical stocks that...
...In contrast, pharmaceutical companies raised just $160mn for antibiotic research, a decline over the decade. Commercial activity and research in antibiotics have been in decline since the 1980s....
...by preventing chronic diseases, could lead to long-term savings: the yearly costs of asthma in the US alone are $56bn, mainly linked to hospital stays, according to the Asthma and Allergy Foundation of America...
...The pharmaceutical company’s market capitalisation recently overtook Tesla thanks to investor enthusiasm over Mounjaro’s success. Earnings are expected to decrease by three cents to $2.11 a share....
...WuXi AppTec is a major supplier of essential ingredients to many of the largest global pharmaceutical companies and conducts drug development for them....
...Pharma: Pharmaceutical groups Bristol Myers Squibb, Regeneron and AbbVie will also report earnings before the market opens....
...An unanticipated boom in demand from China, Latin America, the Middle East and north Africa for alteplase, an off-patent drug used to treat strokes, has led to a shortage of supplies, according to Torsten...
...Gilead Sciences fell 10.5 per cent after the pharmaceutical company said its treatment for lung cancer failed to improve the survival of patients in its latest trial....
...It predominantly affects people of colour and is prevalent in sub-Saharan Africa, Latin America, the Middle East and India....
...Large drugmakers have also underperformed, with the S&P 500 pharmaceutical sub-index heading for its worst performance relative to the broader S&P 500 in at least 20 years....
...It was unbelievable,” said Alisha Alaimo, Biogen’s North America head....
...Eli Lilly was once considered something of an also-ran in the pharmaceutical industry....
...IAG said it had increased flights to the “strongly growing” Latin America and Caribbean region....
International Edition